SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055682
Filing Date
2006-03-16
Accepted
2006-03-16 07:08:42
Documents
12
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2005 d10k.htm 10-K 1246308
2 LICENSE AGREEMENT, AS AMENDED, DATED MARCH 14, 2006 - CHUGAI PHAMACEUTICALS dex1026.htm EX-10.26 11139
3 STATEMENT RE: COMPUTATION OF RATION OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 19761
4 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1011
5 CONSENT OF STONEFIELD JOSEPHSON, INC. dex231.htm EX-23.1 1628
6 CONSENT OF GRANT THORNTON LLP dex232.htm EX-23.2 1857
7 CONSENT OF ERNST & YOUNG LLP dex233.htm EX-23.3 2074
8 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 8647
9 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 8835
10 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 8137
11 GRAPHIC g97493img001.jpg GRAPHIC 4950
12 GRAPHIC g97493img002.jpg GRAPHIC 2959
  Complete submission text file 0001193125-06-055682.txt   1322006
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 06689975
SIC: 2834 Pharmaceutical Preparations